IGF-1 LR3 (Insulin-Like Growth Factor-1 Long Arg3)
IGF-1 LR3 is a synthetic analog of insulin-like growth factor-1 (IGF-1), engineered for enhanced stability and prolonged activity in research environments. Structural modifications, including an arginine substitution and extended peptide chain, distinguish it from native IGF-1 and make it a valuable compound for cellular growth and signaling studies.
In laboratory research, IGF-1 LR3 is primarily studied for its interaction with IGF-1 receptors, which play a critical role in cell growth, differentiation, and metabolic signaling. These receptors are widely distributed across tissues, making the compound relevant in diverse biological research models.
One of the defining characteristics of IGF-1 LR3 is its reduced affinity for IGF-binding proteins. This modification allows for extended receptor availability and sustained signaling, enabling researchers to observe longer-lasting cellular responses in controlled experimental settings.
IGF-1 LR3 is frequently examined in studies focused on cell proliferation and tissue signaling pathways. Researchers explore how prolonged IGF-1 receptor activation influences cellular development, regeneration-related signaling, and adaptive growth processes.
The compound is also of interest in metabolic research. IGF-1 signaling is closely linked to nutrient utilization, glucose transport, and anabolic balance, making IGF-1 LR3 useful for investigating metabolic coordination at the cellular level.
In muscle and connective tissue research models, IGF-1 LR3 is studied for its role in cellular communication related to growth and repair signaling. Its extended activity profile supports observation of long-term cellular adaptation rather than short-term responses.
Unlike endocrine hormones that act broadly, IGF-1 LR3 is studied for its receptor-specific signaling behavior. This targeted interaction allows researchers to focus on downstream molecular pathways without widespread systemic activation.
Researchers also investigate IGF-1 LR3 in gene expression studies, examining how IGF-related signaling influences transcription factors involved in growth and cellular maintenance.
The peptide’s predictable molecular behavior supports reproducibility in laboratory experiments. Its consistent receptor interaction makes it suitable for comparative studies and standardized research protocols.
IGF-1 LR3 is often included in advanced growth-factor research to better understand how structural peptide modifications alter biological activity and signaling duration.
Because growth and metabolism are interconnected systems, IGF-1 LR3 is commonly used in systems-based research rather than isolated pathway analysis. This allows for a broader view of cellular coordination.
The compound’s enhanced stability compared to native IGF-1 makes it particularly valuable for extended in-vitro and in-vivo research models where consistent signaling is required.
IGF-1 LR3 continues to attract scientific interest due to its refined structure, prolonged activity, and relevance to growth-factor signaling science.
As peptide research advances, IGF-1 LR3 remains an important tool for exploring how sustained IGF-1 receptor activation influences cellular growth, adaptation, and metabolic regulation within complex biological systems.
New
IGF-1 LR3 (Insulin-Like Growth Factor-1 Long Arg3) 1mg
$195.00
IGF-1 LR3 is a synthetic analog of insulin-like growth factor-1 (IGF-1), engineered for enhanced stability and prolonged activity in research environments. Structural modifications, including an arginine substitution and extended peptide chain, distinguish it from native IGF-1 and make it a valuable compound for cellular growth and signaling studies.
Description
Shipping & Delivery
Related products
BPC-157 15mg
BPC-157 has undergone a great deal of research because its healing abilities extend well beyond the lining of the stomach. Studies in animal models indicate that BPC-157 can enhance angiogenesis, promote wound healing, stimulate collagen synthesis, modulate the inflammatory response, and protect against oxidative stress. The peptide has shown benefits in animal models with inflammatory bowel disease, GI ulcers, musculoskeletal injuries, heart damage, eye injuries and neurological damage. Research has shown that the oral bioavailability of BPC-157 is quite high. BPC-157, TB-500, KPV, GHK-Cu 80mg (Klow Blend)
BPC-157 has undergone a great deal of research because its healing abilities extend well beyond the lining of the stomach. Studies in animal models indicate that BPC-157 can enhance angiogenesis, promote wound healing, stimulate collagen synthesis, modulate the inflammatory response, and protect against oxidative stress. The peptide has shown benefits in animal models with inflammatory bowel disease, GI ulcers, musculoskeletal injuries, heart damage, eye injuries and neurological damage. Research has shown that the oral bioavailability of BPC-157 is quite high. 
Dihexa (5mg x 60 Capsules = 300mg)
Dihexa is a small peptide-derived compound designed to support cognitive function and brain regeneration. It acts by activating the HGF/c-Met signaling pathway, which plays a critical role in forming new synaptic connections and enhancing neuroplasticity. Dihexa also mimics the action of brain-derived neurotrophic factor (BDNF), a key molecule involved in learning, memory, and neuronal survival. Preclinical research studies have shown that Dihexa can significantly improve memory consolidation and reverse cognitive deficits in models of Alzheimer’s disease, traumatic brain injury, and stroke. Unlike traditional nootropics or growth factors with poor blood–brain barrier penetration, Dihexa is orally bioavailable and metabolically stable, allowing for targeted CNS effects. Its unique mechanism positions it as a promising research compound for neurodegenerative conditions, offering potential in synaptic repair, inflammation reduction, and long-term cognitive enhancement. 
GHK-Cu 50mg Copper Peptide
GHK-Cu is a small, naturally occurring peptide with the ability to attenuate inflammation, improve antioxidant responses, and improve gene expression on a large scale. Research shows that this copper-chelating peptide may be of critical importance both in the prevention of neurodegenerative disease and as a tool for exploring pathophysiological mechanisms. Studies in mice have revealed that GHK-Cu can protect against neurological insults, improve wound healing, reduce rates of infection, and boost blood vessel growth. The peptide has been of interest in recent years for its anti-oxidant properties that, in combination with its ability to alter gene expression patterns, appear to help slow or even reverse some aspects of aging.
TB-500 (Thymosin Beta-4) (43aa) (2mg x 10 Vials = 20mg)
TB-500 (Thymosin Beta-4) is a 43 amino acid peptide sequence. In animal models, Thymosin Beta-4 has been shown to improve blood vessel growth, regulate wound healing, decrease inflammation, and reduce oxidative damage in the heart and central nervous system. Thymosin-beta-4 has a role in protection, tissue repair, regeneration and remodeling of injured or damaged tissues. It is also of active interest in anti-aging research.
Reviews
There are no reviews yet.